Recurrent Miscarriage and IVF: Testing, Embryo Genetics, and Treatment Planning

Recurrent miscarriage is commonly evaluated after two or more clinical pregnancy losses, although definitions may vary by guideline and country. Testing usually focuses on uterine anatomy, parental chromosomes, antiphospholipid syndrome, thyroid and metabolic health, and selected male or genetic factors.
Key Takeaways
- Recurrent miscarriage is commonly evaluated after two or more clinical pregnancy losses, although definitions may vary by guideline and country.
- Testing usually focuses on uterine anatomy, parental chromosomes, antiphospholipid syndrome, thyroid and metabolic health, and selected male or genetic factors.
- Embryo genetic testing can help identify chromosomally suitable embryos for transfer, but it cannot guarantee pregnancy or prevent every miscarriage.
- Treatment planning may include correcting uterine problems, managing endocrine or autoimmune conditions, optimizing lifestyle, and choosing an IVF strategy.
- Many couples still achieve a successful pregnancy after recurrent miscarriage, especially with careful evaluation, realistic counseling, and supportive care.
Recurrent miscarriage can be emotionally and physically difficult, but a structured evaluation often identifies treatable factors and helps guide fertility planning. IVF, embryo genetic testing, and individualized medical care may be considered depending on age, history, test results, and pregnancy goals.
Overview
Recurrent miscarriage, also called recurrent pregnancy loss, generally means two or more losses of a clinically recognized pregnancy. Some guidelines begin a full evaluation after two losses, while others historically used three; in practice, many specialists recommend earlier assessment when the woman is older, losses were later in pregnancy, there is infertility, or the couple feels ready to investigate.
Miscarriage has many possible causes, and in a significant number of cases no single cause is found. This does not mean that nothing can be done. A careful review of the pregnancy history, targeted testing, and an individualized plan can help identify treatable factors and avoid unnecessary interventions.
For some couples, IVF treatment becomes part of the plan because it allows embryos to be created in the laboratory and, when appropriate, genetically tested before transfer. IVF may be especially relevant when recurrent miscarriage occurs together with infertility, advanced maternal age, severe male-factor infertility, or a known chromosomal rearrangement in one parent.
How Recurrent Miscarriage Is Assessed
The first step is a detailed consultation. The fertility specialist usually reviews the number and timing of losses, whether a heartbeat was seen, results of any pregnancy tissue testing, previous births, menstrual patterns, medical conditions, medications, surgeries, family history, and lifestyle factors. The male partner’s health and reproductive history are also relevant, because sperm quality and parental genetics can influence embryo development.
Evaluation is usually targeted rather than unlimited. Commonly recommended tests may include parental karyotyping, blood tests for antiphospholipid syndrome, thyroid function tests, diabetes screening when indicated, and assessment of the uterus. Uterine evaluation may be performed with ultrasound, saline infusion sonography, hysteroscopy, or other imaging depending on the clinical situation.
Additional testing may be considered selectively. For example, prolactin, ovarian reserve markers, genetic carrier screening, sperm analysis, or sperm DNA fragmentation testing may be useful in certain cases. Inherited thrombophilia testing is not routinely recommended for every patient with early recurrent miscarriage, but it may be considered after later pregnancy loss or when there is a personal or strong family history of blood clots.
Common Causes and Risk Factors
The most common biological reason for early miscarriage is an embryo chromosome abnormality, known as aneuploidy. The chance of aneuploidy increases with maternal age because egg chromosome division becomes less reliable over time. In many cases, aneuploidy happens by chance and is not inherited.
Other causes can include uterine factors such as a septate uterus, significant adhesions, submucosal fibroids, or endometrial polyps that affect the uterine cavity. Hormonal and metabolic conditions may also contribute, including untreated thyroid disease, poorly controlled diabetes, and sometimes ovulatory disorders such as polycystic ovary syndrome.
Immune and clotting-related factors are carefully separated into evidence-based and unproven categories. Antiphospholipid syndrome is a recognized autoimmune condition associated with recurrent miscarriage and later pregnancy complications. By contrast, many proposed immune causes and treatments, such as routine natural killer cell testing, intralipid infusions, or intravenous immunoglobulin, are not recommended as standard care without clear indications or research protocols.
Parental chromosome rearrangements, such as balanced translocations, are uncommon but important because they can increase the chance of embryos with unbalanced chromosomes. Lifestyle factors, including smoking, heavy alcohol use, certain recreational drugs, high caffeine intake, and obesity, may also reduce pregnancy health and are usually addressed as part of a comprehensive plan.
Embryo Genetics and IVF Planning
IVF allows eggs and sperm to be combined outside the body, embryos to be monitored as they develop, and one embryo to be selected for transfer. When recurrent miscarriage is suspected to be related to embryo chromosome abnormalities, preimplantation genetic testing for aneuploidy, or PGT-A, may be discussed. PGT-A involves taking a small sample from the outer cells of a blastocyst-stage embryo and testing the chromosome number.
PGT-A can help reduce the chance of transferring an embryo with clear aneuploidy, which may reduce miscarriage risk per transfer in some groups, particularly older patients or those with repeated losses related to chromosomal errors. However, it does not guarantee implantation, a live birth, or a miscarriage-free pregnancy. Embryos can also be mosaic, meaning the biopsy may show a mixture of normal and abnormal cells, which requires careful counseling.
If one parent has a known balanced translocation or other structural chromosome rearrangement, preimplantation genetic testing for structural rearrangements, or PGT-SR, may be recommended. This testing is different from routine PGT-A and is designed to identify embryos more likely to have the correct chromosomal balance. Genetic counseling is often valuable before and after testing so couples understand what results can and cannot predict.
IVF planning also includes decisions about ovarian stimulation, fertilization method, embryo culture, freezing, transfer timing, and how many embryos to transfer. In many situations, single embryo transfer is preferred to reduce the risks of twins or higher-order pregnancy. If there is significant male-factor infertility, ICSI may be discussed as part of the fertilization strategy.
Treatment Options Based on Test Results
Treatment depends on the cause, when one is identified. A uterine septum, significant adhesions, or certain cavity-distorting fibroids may be treated surgically, usually with minimally invasive techniques. The goal is to improve the uterine environment before trying to conceive naturally or proceeding with embryo transfer.
Antiphospholipid syndrome is one of the clearest examples of a treatable recurrent miscarriage factor. When diagnostic criteria are met, specialists may recommend medications such as low-dose aspirin and heparin during pregnancy, but these should only be used under medical supervision. They are not appropriate for every patient with miscarriage history.
Endocrine and metabolic conditions are managed before conception whenever possible. This may include optimizing thyroid function, improving blood glucose control, addressing ovulation disorders, reviewing medications for pregnancy safety, and supporting a healthy body weight. Patients who have irregular cycles, suspected ovulatory problems, or overlapping infertility may benefit from a structured female infertility evaluation.
Progesterone support may be considered in selected situations, especially in women with early pregnancy bleeding and a history of miscarriage, depending on local guidelines and physician judgment. In IVF cycles, progesterone is routinely used for luteal support after embryo transfer. Antibiotics, steroids, blood thinners, or immune treatments should not be used simply because miscarriages occurred unless there is a clear medical indication.
Prevention, Self-Care, and Emotional Support
Not all miscarriages can be prevented, and patients should be reassured that ordinary daily activities, mild exercise, working, or a single episode of stress are not typical causes of pregnancy loss. Still, preconception health can make a meaningful difference. A clinician may recommend folic acid, review medications, update vaccinations, and advise on managing chronic conditions before pregnancy.
Helpful self-care steps often include stopping smoking, avoiding recreational drugs, limiting alcohol while trying to conceive, moderating caffeine, maintaining a balanced diet, and aiming for regular physical activity. Weight management should be approached respectfully and medically, especially when there are hormonal conditions, insulin resistance, or eating concerns.
Emotional recovery is just as important as physical evaluation. Recurrent miscarriage can create grief, anxiety, guilt, and fear during future pregnancies. Counseling, pregnancy loss support groups, and clear communication with the care team can help couples make decisions at a pace that feels manageable.
During a new pregnancy after recurrent loss, some patients benefit from early ultrasound monitoring and scheduled check-ins. These visits cannot remove all uncertainty, but they can provide reassurance, detect concerns early, and help the patient feel supported during a stressful time.
When to See a Fertility Specialist
A fertility or reproductive medicine specialist should be consulted after two or more clinical miscarriages, after one later pregnancy loss, or sooner if there is known infertility, maternal age over 35, irregular cycles, a history of uterine surgery, or a known genetic issue in either partner. Couples may also seek care when they want a second opinion about testing, embryo genetics, or whether IVF is appropriate.
Urgent medical care is needed during a miscarriage if there is very heavy bleeding, fainting, severe pain, fever, foul-smelling discharge, or concern for ectopic pregnancy. In non-urgent situations, a planned consultation after recovery allows the doctor to review records and design an evidence-based evaluation.
For international patients seeking coordinated assessment, Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals can diagnose and treat recurrent miscarriage and infertility using individualized plans. The most appropriate approach depends on the couple’s history, test results, age, embryo information, and preferences.
Frequently asked questions
How many miscarriages are considered recurrent miscarriage?
Many reproductive medicine guidelines define recurrent miscarriage as two or more clinical pregnancy losses. Some older definitions used three losses, but evaluation is often offered after two, especially when age, infertility, later loss, or patient concern makes earlier testing reasonable.
Can IVF prevent miscarriage?
IVF cannot prevent every miscarriage because pregnancy loss can occur for many reasons, including uterine, medical, placental, and unexplained factors. However, IVF with appropriate embryo genetic testing may reduce the chance of transferring an embryo with a major chromosome abnormality in selected patients.
What is PGT-A, and who may benefit from it?
PGT-A is preimplantation genetic testing for aneuploidy, which checks whether an embryo has the expected number of chromosomes. It may be considered for patients with recurrent miscarriage, advanced maternal age, repeated IVF failure, or a history suggesting embryo chromosome problems. Its benefits and limitations should be discussed with a fertility specialist.
Should both partners be tested after recurrent miscarriage?
Yes, evaluation often includes both partners. The female partner may need uterine, hormonal, autoimmune, and metabolic assessment, while the male partner may need semen analysis and, in selected cases, additional sperm or genetic testing. Parental karyotyping can identify rare chromosome rearrangements in either partner.
Are blood thinners always needed after recurrent miscarriage?
No. Blood thinners are typically recommended only when there is a specific indication, such as confirmed antiphospholipid syndrome or another medically justified clotting condition. Using aspirin or heparin without a diagnosis may add risk without proven benefit, so treatment should be individualized.
What if all recurrent miscarriage tests are normal?
Unexplained recurrent miscarriage is common, and normal results can still be useful because they help avoid unnecessary or unproven treatments. Many couples with unexplained losses can still have a successful pregnancy, sometimes with supportive monitoring, optimized preconception health, and carefully planned natural conception or IVF.
This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.
IVF & fertility treatment in Turkey — success rates and costs
JCI-accredited · board-certified surgeons · reply within 24h
Add us as a Preferred Source to see more of our trusted health content across Google Search, AI Overviews and Discover.
Related Treatments
Related Conditions
More from the Health Library

PGT in IVF: Embryo Genetic Testing, Benefits, and Limits

Semen Analysis: What Male Fertility Test Results Mean

IVF After Miscarriage: When to Restart and What to Check First

Who Is a Good Candidate for ICSI Treatment?

IVF After Miscarriage: When to Try Again and What to Review

IVF After Tubal Ligation: How Treatment Can Bypass Blocked Tubes
Gynecology & Obstetrics Specialists at Acibadem

Dr. Ahmet Varolan
Gynecology & Obstetrics
Dr. Albert Kazado
Gynecology & Obstetrics
Dr. Alihan Özcan
Gynecology & Obstetrics
Assoc. Prof. Dr. Alpay Yılmaz
Gynecologic Oncology

